Inhibition of human immunodeficiency virus by N-methylisatin-β4′:4′-diethylthiosemicarbazone and N-allylisatin-β-4′:4′-diallythiosemicarbazone
Authors:
- D. RonenDRD. Ronen
- A. VansoverAVA. Vansover
- T. StematskyTST. Stematsky
- J.L. RiggsJRJ.L. Riggs
- 1 August 1994
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 24 (4) , 305-314
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Expression of wild-type and mutant p53 proteins by recombinant vaccinia virusesNucleic Acids Research, 1992
- Evaluation of new antiviral agents: I. In vitro perspectivesAntiviral Research, 1989
- N-methylisatin-beta-4',4'-diethylthiosemicarbazone, an inhibitor of Moloney leukemia virus protein production: characterization and in vitro translation of viral mRNAAntimicrobial Agents and Chemotherapy, 1987
- Effect of N-methylisatin-β-4′:4′-diethylthiosemicarbazone on intracellular Moloney leukemia virus constituentsAntiviral Research, 1985
- Infection of HTLV-III/LAV in HTLV-I-Carrying Cells MT-2 and MT-4 and Application in a Plaque AssayScience, 1985
- Inhibition of the synthesis of Moloney leukemia virus structural proteins by N-methylisatin-beta-4',4'-diethylthiosemicarbazoneAntimicrobial Agents and Chemotherapy, 1984
- Isolation of Lymphocytopathic Retroviruses from San Francisco Patients with AIDSScience, 1984
- Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDSScience, 1984
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- CLINICAL EXPERIENCE WITH THE ANTIVIRAL DRUG MARBORAN® (1‐METHYLISATIN 3‐THIOSEMICARBAZONE) *Annals of the New York Academy of Sciences, 1965